Cargando…

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring

Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeetu, G, Anusha, G
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964775/
https://www.ncbi.nlm.nih.gov/pubmed/21042493
http://dx.doi.org/10.4103/0975-1483.66802
_version_ 1782189431652876288
author Jeetu, G
Anusha, G
author_facet Jeetu, G
Anusha, G
author_sort Jeetu, G
collection PubMed
description Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled, and to understand the pharmacovigilance, a high level of expertise is required to rapidly detect drug risks as well as to defend the product against an inappropriate removal. The current global network of pharmacovigilance centers, coordinated by the Uppsala Monitoring Centre, would be strengthened by an independent system of review. This would consider litigious and important drug safety issues that have the potential to affect public health adversely beyond national boundaries. Recently, pharmacovigilance has been confined, mainly to detect adverse drug events that were previously either unknown or poorly understood. Pharmacovigilance is an important and integral part of clinical research and these days it is growing in many countries. Today many pharmacovigilance centers are working for drug safety monitoring in this global pitch, however, at the turn of the millennium pharmacovigilance faces major challenges in aspect of better safety and monitoring of drugs. In this review we will discuss about drug safety, worldwide pharmacovigilance centers and their role, benefits and challenges of pharmacovigilance and its future consideration in healthcare sectors.
format Text
id pubmed-2964775
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29647752010-11-01 Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring Jeetu, G Anusha, G J Young Pharm General Pharmacy Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled, and to understand the pharmacovigilance, a high level of expertise is required to rapidly detect drug risks as well as to defend the product against an inappropriate removal. The current global network of pharmacovigilance centers, coordinated by the Uppsala Monitoring Centre, would be strengthened by an independent system of review. This would consider litigious and important drug safety issues that have the potential to affect public health adversely beyond national boundaries. Recently, pharmacovigilance has been confined, mainly to detect adverse drug events that were previously either unknown or poorly understood. Pharmacovigilance is an important and integral part of clinical research and these days it is growing in many countries. Today many pharmacovigilance centers are working for drug safety monitoring in this global pitch, however, at the turn of the millennium pharmacovigilance faces major challenges in aspect of better safety and monitoring of drugs. In this review we will discuss about drug safety, worldwide pharmacovigilance centers and their role, benefits and challenges of pharmacovigilance and its future consideration in healthcare sectors. Medknow Publications 2010 /pmc/articles/PMC2964775/ /pubmed/21042493 http://dx.doi.org/10.4103/0975-1483.66802 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle General Pharmacy
Jeetu, G
Anusha, G
Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title_full Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title_fullStr Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title_full_unstemmed Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title_short Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
title_sort pharmacovigilance: a worldwide master key for drug safety monitoring
topic General Pharmacy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964775/
https://www.ncbi.nlm.nih.gov/pubmed/21042493
http://dx.doi.org/10.4103/0975-1483.66802
work_keys_str_mv AT jeetug pharmacovigilanceaworldwidemasterkeyfordrugsafetymonitoring
AT anushag pharmacovigilanceaworldwidemasterkeyfordrugsafetymonitoring